Obstetrics, gynecology and reproductive medicine guidelines

Breast diseases

Guidelines, reviews, statements, recommendations, standards

Benign breast diseases

• Canada
  • Society of Obstetricians and Gynaecologists of Canada
    • Mastalgia [2006]
• United Kingdom
  • Attract
    • Management of breast pain in women of reproductive age in primary care. [2007]
• United States of America
  • National Guideline Clearinghouse
    • Common breast problems. University of Michigan Health System [2007]
    • Mastalgia. Society of Obstetricians and Gynaecologists of Canada [2006]
  • University of Michigan Health System
    • Breast Problems: Common Problems in Adults [2007]
• Articles in journals
  • American Family Physician
    • Breast Cyst Aspiration [2003]
  • Cancer Control: Journal of the Moffitt Cancer Center
    • High-risk benign breast lesions: current strategies in management [2007]
  • Journal of Clinical Pathology
    • Pathology and clinical relevance of radial scars: a review [2003]
  • RadioGraphics
    • Breast US in Children and Adolescents [2000]
• {Related topics}
  • Guidelines
    • Mastitis
    • Mammography
    • Gynecomastia
    • Breast plastic surgery
    • Breast imaging
    • Breast cancer
    • Breast biopsy, breast pathology

Breast biopsy, breast pathology

• Australia
  • Cancer Council Australia
    • The Pathology Reporting of Breast Cancer [2001]
  • Medical Services Advisory Committee
    • Advanced Breast Biopsy Instrumentation (ABBI®) System for non-palpable breast lesions [2001]
• Australia, New Zealand
  • Royal Australasian College of Surgeons
    • Advanced Breast Biopsy Instrumentation System [2000]
• United Kingdom
  • National Institute for Health and Clinical Excellence
    • Image-guided radiofrequency excision biopsy of breast lesions [2009]
    • Image-guided vacuum assisted excision biopsy of benign breast lesions [2006]
  • Royal College of Pathologists
    • Breast [2005]
• United States of America
  • American College of Radiology
    • ACR Practice Guideline for the Performance of Ultrasound-Guided Percutaneous Breast Interventional Procedures [2006]
    • ACR Practice Guideline for the Performance of Stereotactically Guided Breast Interventional Procedures [2006]
  • American College of Surgeons
    • Physician qualifications for stereotactic breast biopsy: A revised statement [1998]
• Articles in journals
  • British Journal of Radiology
    • Improving the sensitivity of stereotactic core biopsy to diagnose ductal carcinoma in situ of the breast: a mathematical model [2001]
  • British Medical Journal
    • Studies of apoptosis in breast cancer [2001]
  • RadioGraphics
    • Missed Breast Cancers at US-guided Core Needle Biopsy: How to Reduce Them [2007]
• {Related topics}
  • Guidelines
    • Sentinel lymph node biopsy
    • Breast cancer
    • Benign breast diseases

Breast cancer

• Australia
  • National Breast and Ovarian Cancer Centre
    • The investigation of a new breast symptom - guide for GPs [2006]
    • Evidence Relevant to Guidelines for the Investigation of Breast Symptoms [2006]
    • The management of the woman with metastatic breast cancer [2003]
    • Clinical practice guidelines for the management and support of younger women with breast cancer [2003]
    • Clinical management of DCIS, LCIS and atypical hyperplasia of the breast [2003]
  • National Health and Medical Research Council
    • Psychosocial Clinical Practice Guidelines: Information, Support and Counselling for Women With Breast Cancer [2000]
• Australia, New Zealand
  • Royal Australasian College of Surgeons
    • National Breast Cancer Audit [2005]
• Canada
  • BC Cancer Agency
    • Breast Cancer [2005]
  • Cancer Care Ontario
    • Breast Cancer Practice Guidelines [Collection of guidelines]
    • Baseline Staging Tests in Primary Breast Cancer [2003]
  • Public Health Agency of Canada
    • Breast Cancer [Collection of guidelines]
    • Canadian Breast Cancer Initiative Community Capacity Building Transitional Year [2004]
    • Workshop Report: Identification of Research Needs in Breast Cancer Etiology [2001]
• Europe
  • European Society for Medical Oncology
    • Recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up [2007]
    • Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up [2007]
  • European Society of Mastology
    • Guidelines [Collection of guidelines]
    • Quality assurance in the diagnosis of breast disease [2001]
    • The requirements of a specialist breast unit [2000]
• International
  • Cochrane Library
    • Methods of communicating a primary diagnosis of breast cancer to patients [2009]
• Ireland
  • Womens Health Council
    • Survey of views and Perceptions of Women who attended Symptomatic Breast Clinics [2000]
• Netherlands
  • Institute for Medical Technology Assessment
    • Cost of Breast Cancer, Metastatic to the Bone, in the Netherlands [2004]
• New Zealand
  • Ministry of Health
    • Management of Early Breast Cancer - Evidence-based Best Practice Guideline [2009]
• Uganda
  • African Health Sciences
    • Breast cancer guidelines for Uganda (2nd Edition 2008) [2008]
• United Kingdom
  • Bandolier
    • Cancer [Collection of guidelines]
  • British Association of Surgical Oncology
    • The Management of Metastatic Bone Disease in the United Kingdom [1999]
  • National Institute for Health and Clinical Excellence
    • Early and locally advanced breast cancer [2009]
    • Advanced breast cancer [2009]
  • Scottish Intercollegiate Guidelines Network
    • Management of breast cancer in women [2005]
• United States of America
  • Agency for Healthcare Research and Quality
    • Measuring the Quality of Breast Cancer Care in Women [2004]
    • Diagnosis and Management of Specific Breast Abnormalities [2001]
  • American Society of Clinical Oncology
    • Breast Cancer [Collection of guidelines]
    • 1998 Update of Recommended Breast Cancer Surveillance Guidelines [1999]
  • CDC Cancer Prevention and Control
    • Breast Cancer [Collection of guidelines]
  • Collaborative Staging Task Force
    • Breast [2006]
  • College of American Pathologists
    • Breast [2005]
  • Fred Hutchinson Cancer Research Center
    • Breast Health Global Initiative [Collection of guidelines]
  • Institute for Clinical Systems Improvement
    • Diagnosis of Breast Disease [2008]
  • Lab Tests Online - American Association for Clinical Chemistry
    • Breast Cancer [2008]
  • M.D. Anderson Cancer Center
    • Breast Cancer [Collection of guidelines]
  • National Cancer Institute
    • Breast Cancer [Collection of guidelines]
  • National Comprehensive Cancer Network
    • Breast Cancer [2008]
    • Breast Cancer Risk Reduction [2007]
  • National Guideline Clearinghouse
    • Early and locally advanced breast cancer. Diagnosis and treatment. National Collaborating Centre for Cancer [2009]
    • Advanced breast cancer. Diagnosis and treatment. National Collaborating Centre for Cancer [2009]
    • Guideline implementation for breast healthcare in low-income and middle-income countries. Breast Health Global Initiative [2008]
    • Diagnosis of breast disease. Institute for Clinical Systems Improvement [2008]
    • Can Guidelines Addressing Resource Allocation Improve Breast Health Outcome for Low and Middle Income Countries? - Expert Commentary [2008]
    • Stage 1 breast carcinoma. American College of Radiology [2006]
    • Breast cancer in limited-resource countries: early detection and access to care. Breast Health Global Initiative [2006]
    • Breast cancer in limited-resource countries: diagnosis and pathology. Breast Health Global Initiative [2006]
    • Management of breast cancer in women. A national clinical guideline. Scottish Intercollegiate Guidelines Network [2005]
  • OncoLink
    • Breast Cancer [Collection of guidelines]
• Articles in journals
  • American Journal of Pathology
    • Breast Cancer Metastasis to the Central Nervous System [2005]
  • Australian Family Physician
    • Metastatic breast cancer [2006]
    • Breast cancer - New and emerging technologies for diagnosis and management [2005]
  • Australian Prescriber
    • Managing healthy women at risk of breast cancer [2002]
  • BMC Public Health
    • Korean women: breast cancer knowledge, attitudes and behaviors [2001]
  • Breast Cancer Research
    • Evaluation of the current knowledge limitations in breast cancer research: a gap analysis [2008]
    • Molecular biology of breast cancer metastasis: Inflammatory breast cancer: clinical syndrome and molecular determinants [2000]
  • British Medical Journal
    • Breast cancer in men [2003]
    • Breast cancer [2002]
    • Breast cancer - epidemiology, risk factors, and genetics [2000]
    • Breast cancer [2000]
  • CA - A Cancer Journal for Clinicians
    • Breast Cancer Staging: Working With the Sixth Edition of the AJCC Cancer Staging Manual [2006]
    • Trends in Breast Cancer by Race and Ethnicity [2003]
  • Canadian Family Physician
    • Approach to inflammatory breast cancer [2009]
  • Canadian Medical Association Journal
    • Baseline staging tests in primary breast cancer: a practice guideline [2001]
  • Cancer Epidemiology Biomarkers & Prevention
    • Epidemiology and Prevention of Breast Cancer [2005]
  • Health and Quality of Life Outcomes
    • Quality of life assessment in women with breast cancer: Benefits, acceptability and utilization [2007]
  • Japanese Journal of Clinical Oncology
    • Detection of the First Recurrence During Intensive Follow-up of Breast Cancer Patients [1998]
  • Journal of Cancer Research and Therapeutics
    • Brain metastases from breast cancer: Management approach [2007]
  • Journal of Clinical Investigation
    • Breast cancer: origins and evolution [2007]
  • Journal of Korean Medical Science
    • Epidemiology of Breast Cancer in Korea: Occurrence, High-Risk Groups, and Prevention [2002]
  • Journal of Nutrition
    • Can Lifestyle Modification Increase Survival in Women Diagnosed with Breast Cancer? [2002]
  • Journal of the National Cancer Institute
    • Role of Detection Method in Predicting Breast Cancer Survival: Analysis of Randomized Screening Trials [2005]
    • Health-related quality-of-life measurement in randomized clinical trials in breast cancer--taking stock [2003]
  • Mayo Clinic Proceedings
    • Evaluation and Management of Breast Pain [2004]
    • Advances in Screening, Diagnosis, and Treatment of Breast Cancer [2004]
  • Medical Journal of Australia
    • The prevention, detection, and management of breast cancer [2006]
    • Breast cancer guidelines in action [2000]
    • Local impact of the NHMRC early breast cancer guidelines: where to from here? [1997]
  • Yonsei Medical Journal
    • Unilateral breast edema: spectrum of etiologies and imaging appearances [2005]
• {Related topics}
  • Clinical tools, medical calculators, unit conversions, statistics, clinical research tools
    • Breast cancer, breast diseases : Clinical tools, medical calculators
  • Guidelines
    • Sentinel lymph node biopsy
    • Menopause, hormone replacement therapy, breast cancer
    • Mammography
    • Gynecologic oncology
    • Familial breast cancer
    • Breast plastic surgery
    • Breast imaging
    • Breast cancer treatment
    • Breast cancer stem cells
    • Breast cancer screening
    • Breast cancer risk, biological markers
    • Breast cancer and pregnancy
    • Breast biopsy, breast pathology
    • Benign breast diseases

Breast cancer and pregnancy

• Canada
  • Society of Obstetricians and Gynaecologists of Canada
    • Breast Cancer and Abortion [2005]
    • Breast cancer, pregnancy, and breastfeeding [2002]
• United Kingdom
  • Royal College of Obstetricians and Gynaecologists
    • Pregnancy and breast cancer [2004]
• United States of America
  • National Cancer Institute
    • Breast Cancer Treatment and Pregnancy [2004]
  • National Guideline Clearinghouse
    • Pregnancy and breast cancer. Royal College of Obstetricians and Gynaecologists [2004]
• Articles in journals
  • Annals of Oncology
    • Emerging therapeutic options for breast cancer chemotherapy during pregnancy [2008]
  • British Medical Journal
    • Pregnancy and breast cancer [2005]
  • Canadian Family Physician
    • Trastuzumab treatment for breast cancer during pregnancy [2008]
  • Endocrine-Related Cancer
    • Pregnancy and the risk of breast cancer [2007]
  • RadioGraphics
    • Radiologic Evaluation of Breast Disorders Related to Pregnancy and Lactation [2007]
• {Related topics}
  • Guidelines
    • Obstetrics, perinatology
    • Breast cancer

Breast cancer risk, biological markers

• Australia
  • National Breast and Ovarian Cancer Centre
    • Breast cancer risk factors - a review of the evidence [2009]
• Canada
  • Society of Obstetricians and Gynaecologists of Canada
    • Progesterone-only and non-hormonal contraception in the breast cancer survivor : joint review and committee opinion of the Society of Obstetricians and Gynaecologists of Canada and the Society of Gynecologic Oncologists of Canada [2006]
  • Technology Assessment Unit of the McGill University Health Centre
    • Testing for HER2 Positive Breast Cancer: A Cost-Effectiveness Analysis [2006]
• Netherlands
  • Health Council of the Netherlands
    • Night work and breast cancer: a causal relationship? [2006]
• United States of America
  • Agency for Healthcare Research and Quality
    • Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes [2008]
    • HER2 Testing to Manage Patients with Breast or Other Solid Tumors [2008]
  • American Society of Clinical Oncology
    • American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer [2007]
    • ASCO 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer [2007]
    • 2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology [2001]
  • College of American Pathologists
    • HER2 Testing Guidelines and Resources [Collection of guidelines]
  • Evaluation of Genomic Applications in Practice and Prevention
    • Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer? [2009]
  • National Guideline Clearinghouse
    • Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer? [2009]
    • American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer [2007]
    • American Society of Clinical Oncology 2007 update recommendations for the use of tumor markers in breast cancer [2007]
    • Progesterone-only and non-hormonal contraception in the breast cancer survivor: joint review and committee opinion of the Society of Obstetricians and Gynaecologists of Canada and the Society of Gynecologic Oncologists of Canada [2006]
• Articles in journals
  • Acta Oncologica
    • TIMP-1 as a tumor marker in breast cancer - An update [2008]
  • American Family Physician
    • Assessing Breast Cancer Risk in Women [2008]
  • American Journal of Clinical Nutrition
    • Consumption of dairy products and the risk of breast cancer: a review of the literature [2004]
    • Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence [2003]
  • American Journal of Epidemiology
    • Cytochrome P-450 1A1 Gene Polymorphisms and Risk of Breast Cancer: A HuGE Review [2005]
    • CYP3A4 Polymorphisms--Potential Risk Factors for Breast and Prostate Cancer: A HuGE Review [2005]
  • American Journal of Pathology
    • Genes Involved in Breast Cancer Progression: Analysis of Global Changes in Gene Expression or Retroviral Tagging? [2002]
  • Annals of Oncology
    • Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? [2005]
  • Breast Cancer Research
    • Metalloproteinases as Common Effectors of Inflammation and ECM Breakdown in Breast Cancer [2008]
    • Intrauterine environments and breast cancer risk: meta-analysis and systematic review [2008]
    • Alternative Splicing and the Progesterone Receptor in Breast Cancer [2008]
    • p21-activated kinase signaling in breast cancer [2005]
    • Towards an integrated model for breast cancer etiology: The crucial role of the number of mammary tissue-specific stem cells [2005]
    • Deficits in plasma oestradiol measurement in studies and management of breast cancer [2005]
    • The diagnosis and management of pre-invasive breast disease – current challenges, future hopes [2003]
    • The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer [2002]
    • The p53 pathway in breast cancer [2002]
    • Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development [2002]
    • Progesterone receptors - animal models and cell signaling in breast cancer: The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis [2002]
    • Progesterone receptors - animal models and cell signaling in breast cancer: Role of steroid receptor coactivators and corepressors of progesterone receptors in breast cancer [2002]
    • Progesterone receptors - animal models and cell signaling in breast cancer: Progesterone's role in mammary gland development and tumorigenesis as disclosed by experimental mouse genetics [2002]
    • Progesterone receptors - animal models and cell signaling in breast cancer: Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells [2002]
    • Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer? [2002]
    • CCAAT/enhancer binding proteins in normal mammary development and breast cancer [2002]
    • Tumour-stromal interactions: Transforming growth factor-beta isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis [2001]
    • Tumour-stromal interactions: Role of the stroma in mammary development [2001]
    • Tumour-stromal interactions: Reciprocal regulation of extracellular matrix proteins and ovarian steroid activity in the mammary gland [2001]
    • Tumour-stromal interactions: Phenotypic and genetic alterations in mammary stroma - implications for tumour progression [2001]
    • Tumour-stromal interactions: Integrins and cell adhesions as modulators of mammary cell survival and transformation [2001]
    • Telomerase and breast cancer [2001]
    • Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics? [2001]
    • Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play? [2001]
    • Intracellular signaling pathways of ErbB2/HER-2 and family members [2001]
    • Hypoxia and oxidative stress in breast cancer: Oxidative stress - its effects on the growth, metastatic potential and response to therapy of breast cancer [2001]
    • Hypoxia and oxidative stress in breast cancer: Hypoxia signalling pathways [2001]
    • Hypoxia and oxidative stress in breast cancer: Hypoxia and tumourigenesis [2001]
    • Applications of microarray technology in breast cancer research [2001]
  • CA - A Cancer Journal for Clinicians
    • Opportunities and Strategies for Breast Cancer Prevention Through Risk Reduction [2008]
    • Organochlorines and Breast Cancer Risk [2002]
  • Cancer Epidemiology Biomarkers & Prevention
    • Vitamin D, Calcium, and Breast Cancer Risk: A Review [2006]
    • Is the Association between Cigarette Smoking and Breast Cancer Modified by Genotype? A Review of Epidemiologic Studies and Meta-analysis [2006]
    • Role of Lipid Peroxidation in the Epidemiology and Prevention of Breast Cancer [2005]
    • Polymorphisms and Circulating Levels in the Insulin-Like Growth Factor System and Risk of Breast Cancer: A Systematic Review [2005]
    • Flavonoids and Breast Cancer Risk in Italy [2005]
    • Cytochrome P450 1B1 and Catechol-O-Methyltransferase Genetic Polymorphisms and Breast Cancer Risk in Chinese Women: Results from the Shanghai Breast Cancer Study and a Meta-analysis [2005]
    • Cigarette Smoking and the Risk of Breast Cancer in Women: A Review of the Literature [2002]
  • Cancer Research
    • Heparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma Perspective [2006]
    • Caveolin-1, Mammary Stem Cells, and Estrogen-Dependent Breast Cancers [2006]
    • Breast Cancer in African-American Women: Differences in Tumor Biology from European-American Women [2006]
  • Clinical Chemistry
    • Serum Tumor Markers in Breast Cancer: Are They of Clinical Value? [2006]
    • Predictive Markers in Breast and Other Cancers: A Review [2005]
  • Endocrine Reviews
    • Estrogen Receptor Mutations in Human Disease [2005]
    • The Role of Prolactin in Mammary Carcinoma [2003]
    • Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone [2003]
  • Endocrine-Related Cancer
    • Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model [2007]
    • Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression [2007]
    • p53 and breast cancer, an update [2006]
    • Significance, detection and markers of disseminated breast cancer cells [2006]
    • Sex-steroid regulation of vascular endothelial growth factor in breast cancer [2006]
    • Progesterone metabolites in breast cancer [2006]
    • Molecular links between obesity and breast cancer [2006]
    • Microarrays in breast cancer research and clinical practice - the future lies ahead [2006]
    • Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on [2006]
    • Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer [2006]
    • Tissue inhibitor of metalloproteinases-1 in breast cancer [2005]
    • Sex steroid-producing enzymes in human breast cancer [2005]
    • Mammary developmental fate and breast cancer risk [2005]
    • Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer [2005]
    • Breast-tissue sampling for risk assessment and prevention [2005]
  • Endocrinology
    • Spot 14: A Marker of Aggressive Breast Cancer and a Potential Therapeutic Target [2006]
    • Endocrine-Disrupting Compounds and Mammary Gland Development: Early Exposure and Later Life Consequences [2006]
  • Experimental Biology and Medicine
    • The Role of CSF-1 in Normal Physiology of Mammary Gland and Breast Cancer: An Update [2004]
  • Japanese Journal of Clinical Oncology
    • Tobacco Smoking and Breast Cancer Risk: An Evaluation Based on a Systematic Review of Epidemiological Evidence among the Japanese Population [2006]
  • Journal of Korean Medical Science
    • Is body mass index the prognostic factor in breast cancer?: a meta-analysis [2001]
  • Journal of Nutrition
    • Vitamin D-3 Receptor as a Target for Breast Cancer Prevention [2003]
    • Maternal and Prepubertal Diet, Mammary Development and Breast Cancer Risk [2001]
  • Journal of the National Cancer Institute
    • Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women [2003]
    • Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients [2002]
    • Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies [2002]
    • Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer [1999]
  • Medical Journal of Australia
    • Passive smoking and breast cancer: is the evidence for cause now convincing? [2004]
• {Related topics}
  • Guidelines
    • Familial breast cancer
    • Breast cancer

Breast cancer screening

• Australia
  • Australian Medical Association
    • Breast Cancer Screening [1999]
  • Cancer Council Australia
    • Early detection of breast cancer [2004]
  • Centre for Clinical Effectiveness, Monash Medical Centre
    • Community education for encouraging participation in breast cancer screening in Southeast Asian women [1999]
  • Department of Human Services, State Government of Victoria
    • BreastScreen Victoria [Collection of guidelines]
  • National Breast and Ovarian Cancer Centre
    • Early detection of breast cancer - NBOCC position statement [2004]
• Canada
  • Canadian Task Force on Preventive Health Care
    • Should women be routinely taught breast self-examination to screen for breast cancer? [2001]
    • 1998 Recommendation Rewording: Screening for Breast Cancer [1998]
  • Cancer Care Ontario
    • Breast Screening [Collection of guidelines]
    • Magnetic Resonance imaging screening of women at high risk for breast cancer : a clinical practice guideline [2007]
  • Public Health Agency of Canada
    • Report from the Evaluation Indicators Working Group: Guidelines for Monitoring Breast Screening Program Performance - Second Edition [2007]
    • Organized Breast Cancer Screening Programs in Canada - Report on Program Performance in 2001 and 2002 [2005]
    • Quality Determinants of Organized Breast Cancer Screening Programs [2003]
  • Society of Obstetricians and Gynaecologists of Canada
    • Breast self-examination [2006]
  • Toward Optimized Practice
    • Early detection of breast cancer [2007]
• International
  • Cochrane Library
    • Strategies for increasing the participation of women in community breast cancer screening [2009]
    • Regular self-examination or clinical examination for early detection of breast cancer [2009]
• New Zealand
  • Cancer Society of New Zealand
    • Early Detection of Breast Cancer [2003]
• United Kingdom
  • National Library for Health
    • Breast cancer screening [2006]
  • NHS Breast Screening Programme
    • NHS Breast Screening Programme [Collection of guidelines]
    • Quality assurance guidelines for surgeons in breast cancer screening, Fourth Edition, March 2009 [2009]
  • NHS Quality Improvement Scotland
    • Scottish Breast Screening Programme 2006 Follow-up [2006]
    • Breast Screening - National Overview [2003]
  • UK National Screening Committee
    • Breast cancer screening [2006]
• United States of America
  • Agency for Healthcare Research and Quality
    • Screening: Breast Cancer [2002]
  • American Cancer Society
    • Breast Cancer: Early Detection [2007]
    • American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography [2007]
    • American Cancer Society Guidelines for Breast Cancer Screening: Update 2003 [2003]
  • Association of Women's Health, Obstetric and Neonatal Nurses
    • Breast Health Surveillance [2000]
  • Cancer Detection Programs
    • Breast Cancer [Collection of guidelines]
  • CDC Cancer Prevention and Control
    • National Breast and Cervical Cancer Early Detection Program (NBCCEDP) [Collection of guidelines]
  • Madigan Army Medical Center
    • Breast Mass Referral Guidelines [2003]
  • National Comprehensive Cancer Network
    • Breast Cancer Screening and Diagnosis [2007]
  • National Guideline Clearinghouse
    • Screening for breast cancer [Guideline synthesis]
    • 1) Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. 2) December 2009 addendum [2009]
    • Palpable breast masses. American College of Radiology [2006]
    • Breast self-examination. Society of Obstetricians and Gynaecologists of Canada [2006]
    • Breast cancer screening. American College of Obstetricians and Gynecologists [2003]
• WHO
  • World Health Organization
    • Screening for Breast Cancer
• Articles in journals
  • American Family Physician
    • Screening for Breast Cancer: Current Recommendations and Future Directions [2007]
    • Evaluation of Palpable Breast Masses [2005]
    • The Evaluation of Common Breast Problems [2000]
    • Breast Cancer Diagnosis and Screening [2000]
  • Annals of Oncology
    • Evaluation of service screening mammography in practice: the impact on breast cancer mortality [2005]
  • Australian Family Physician
    • Clinical breast examination for asymptomatic women - Exploring the evidence [2007]
  • BMC Public Health
    • Breast cancer screening beliefs by practice location [2003]
  • British Medical Journal
    • Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study [2004]
    • Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study [2004]
    • Screening for breast cancer [2000]
    • Is clinical breast examination an acceptable alternative to mammographic screening? [2000]
  • CA - A Cancer Journal for Clinicians
    • Performance and Reporting of Clinical Breast Examination: A Review of the Literature [2004]
    • Clinical Breast Examination: Practical Recommendations for Optimizing Performance and Reporting [2004]
    • Breast Cancer Screening: A Final Analysis? [2003]
  • Cancer Epidemiology Biomarkers & Prevention
    • Accuracy of Self-Reported Cancer-Screening Histories: A Meta-analysis [2008]
  • International Journal of Epidemiology
    • Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening [1998]
  • Journal of the American Board of Family Practice
    • Breast Cancer Screening Controversies [2003]
  • Medical Journal of Australia
    • Breast cancer screening [2003]
  • Singapore Medical Journal
    • The Case for Breast Cancer Screening in Singapore [2002]
• {Related topics}
  • Guidelines
    • Mammography
    • Breast imaging
    • Breast cancer

Breast cancer stem cells

• Articles in journals
  • Breast Cancer Research
    • Breast cancer stem cells: implications for therapy of breast cancer [2008]
    • Breast cancer, stem cells and prospects for therapy [2006]
  • Cancer Research
    • Mammary Stem Cells and Mammopoiesis [2006]
  • Cell Cycle
    • Breast tumor heterogeneity: cancer stem cells or clonal evolution? [2007]
• {Related topics}
  • Guidelines
    • Breast cancer

Breast cancer treatment

• Australia
  • National Breast and Ovarian Cancer Centre
    • Recommendations for endocrine therapy treatment of hormone receptor-positive advanced breast cancer [2008]
  • National Health and Medical Research Council
    • Clinical practice guidelines for the management and support of younger women with breast cancer [2003]
    • Clinical practice guidelines for the management of early breast cancer. Second edition [2001]
    • Clinical Practice Guidelines for the Management of Advanced Breast Cancer [2001]
• Canada
  • Cancer Care Ontario
    • The Role of HER2/neu in Systemic and Radiation Therapy for Women with Breast Cancer: A Clinical Practice Guideline [2006]
    • Management of ductal carcinoma in situ of the breast: a clinical practice guideline [2006]
    • Adjuvant Systemic Therapy for Node-Negative Breast Cancer [2003]
  • Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer
    • Clinical practice guidelines for the care and treatment of breast cancer [Collection of guidelines]
    • Clinical practice guidelines for the care and treatment of breast cancer: 9. Follow-up after treatment for breast cancer (2005 update) [2005]
    • Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer [2004]
    • Clinical practice guidelines for the care and treatment of breast cancer: breast radiotherapy after breast-conserving surgery (summary of the 2003 update) [2003]
    • Clinical practice guidelines for the care and treatment of breast cancer: the management of chronic pain in patients with breast cancer (summary of the 2001 update) [2001]
    • Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-positive breast cancer (summary of the 2001 update) [2001]
    • Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update) [2001]
    • Clinical practice guidelines for the care and treatment of breast cancer: 8. Adjuvant systemic therapy for women with node-positive breast cancer (2001 update) [2001]
    • Clinical practice guidelines for the care and treatment of breast cancer: 7. Adjuvant systemic therapy for women with node-negative breast cancer (2001 update) [2001]
    • Clinical practice guidelines for the care and treatment of breast cancer: 5. Management of ductal carcinoma in situ (DCIS) (2001 update) [2001]
    • Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema [2001]
    • Clinical practice guidelines for the care and treatment of breast cancer: 10. The management of chronic pain in patients with breast cancer (2001 update) [2001]
    • Clinical practice guidelines for the care and treatment of breast cancer: 1. The palpable breast lump: information and recommendations to assist decision-making when a breast lump is detected [1998]
• Europe
  • Central European Cooperative Oncology Group
    • Second consensus on medical treatment of metastatic breast cancer [2007]
  • European Society for Medical Oncology
    • ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of primary breast cancer [2005]
    • ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of locally recurrent or metastatic breast cancer (MBC) [2005]
    • ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer [2005]
  • European Society of Mastology
    • Guidelines on endocrine therapy of breast cancer [2002]
• International
  • Annals of Oncology
    • Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005 [2005]
  • Cochrane Library
    • Systemic therapy for treating locoregional recurrence in women with breast cancer [2009]
    • Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus) [2009]
    • Specialist breast care nurses for supportive care of women with breast cancer [2009]
    • Single agent versus combination chemotherapy for metastatic breast cancer [2009]
    • Sequencing of chemotherapy and radiation therapy for early breast cancer [2009]
    • Psychological interventions for women with metastatic breast cancer [2009]
    • Platinum containing regimens for metastatic breast cancer [2009]
    • Physical therapies for reducing and controlling lymphoedema of the limbs [2009]
    • Multi-agent chemotherapy for early breast cancer [2009]
    • LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women [2009]
    • High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer [2009]
    • High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer [2009]
    • Follow-up strategies for women treated for early breast cancer [2009]
    • Exercise for women receiving adjuvant therapy for breast cancer [2009]
    • Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer [2009]
    • Benzo-pyrones for reducing and controlling lymphoedema of the limbs [2009]
    • Antitumour antibiotic containing regimens for metastatic breast cancer [2009]
    • Antibiotics / anti-inflammatories for reducing acute inflammatory episodes in lymphoedema of the limbs [2009]
    • Addition of drug/s to a chemotherapy regimen for metastatic breast cancer [2009]
  • Endocrine-Related Cancer
    • Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatment [2005]
• United Kingdom
  • Health Technology Assessment
    • Time to full publication of studies of anti-cancer medicines for breast cancer and the potential for publication bias: a short systematic review [2008]
    • Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy [2006]
• United States of America
  • Agency for Healthcare Research and Quality
    • Preventive Medication: Breast Cancer [2002]
  • American College of Radiology
    • Locally Advanced Breast Cancer [2007]
  • American Society of Clinical Oncology
    • American Society of Clinical Oncology 2006 Update of the Breast Cancer Follow-Up and Management Guidelines in the Adjuvant Setting [2006]
    • Pharmacologic Interventions for Breast Cancer Risk Reduction Including Tamoxifen, Raloxifene, and Aromatase Inhibition [2002]
  • National Cancer Institute
    • Breast Cancer: Treatment [Collection of guidelines]
  • National Guideline Clearinghouse
    • ACR Appropriateness Criteria® locally advanced breast cancer [2007]
    • Management of ductal carcinoma in situ of the breast. Cancer Care Ontario Practice Guidelines Initiative [2006]
    • Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer. National Institute for Health and Clinical Excellence [2006]
    • Breast cancer in limited-resource countries: treatment and allocation of resources. Breast Health Global Initiative [2006]
    • American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting [2006]
• Articles in journals
  • Annals Academy of Medicine Singapore
    • The feminist approach in the decision-making process for treatment of women with breast cancer [2006]
  • Annals of Oncology
    • Effective oral chemotherapy for breast cancer: pillars of strength [2008]
    • A review of the use of trastuzumab (Herceptin(R)) plus vinorelbine in metastatic breast cancer [2008]
    • Adjuvant treatment of breast cancer: sequence and duration of hormonal therapy [2006]
    • New developments in the treatment of metastatic breast cancer: from chemotherapy to biological therapy [2005]
    • Neo-adjuvant therapy in breast cancer [2005]
    • An integrated approach for tailored treatment in breast cancer [2005]
    • Adjuvant treatment for early breast cancer [2005]
  • Australian Family Physician
    • Survivorship care after breast cancer [2008]
    • Life after breast cancer [2006]
    • Breast Cancer. Guiding your patient through treatment [2006]
    • Management of early breast cancer - The current approach [2005]
  • Biology of Reproduction
    • Targeting Breast and Prostate Cancers Through Their Hormone Receptors [2005]
  • Breast Cancer
    • Recent perspectives of endocrine therapy for breast cancer [2007]
    • Optimizing the antihormonal treatment and prevention of breast cancer [2007]
    • Economic evaluation of the prevention and treatment of breast cancer--present status and open issues [2007]
    • Current status of health outcome assessment of medical treatment in breast cancer [2007]
    • Current clinical trials of endocrine therapy for breast cancer [2007]
  • Breast Cancer Research
    • Molecular targeted therapies for breast cancer treatment [2008]
    • Hypoxia and oxidative stress in breast cancer: Tumour hypoxia – therapeutic considerations [2001]
    • Breast cancer chemoprevention: beyond tamoxifen [2001]
  • CA - A Cancer Journal for Clinicians
    • Diagnosis and Treatment of Breast Cancer in the Elderly [2003]
  • Canadian Medical Association Journal
    • Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis [2006]
    • Variations in the treatment of early-stage breast cancer in Quebec between 1988 and 1994 [1999]
  • Clinical Cancer Research
    • Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac Problems [2008]
    • Skeletal Complications of Breast Cancer Therapies [2006]
    • A Meta-Analysis on the Interaction between HER-2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer [2005]
  • Clinical Medicine & Research
    • NSABP Breast Cancer Clinical Trials: Recent Results and Future Directions [2003]
  • Endocrine Reviews
    • Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance [2008]
  • Endocrine-Related Cancer
    • Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer [2006]
    • Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk [2006]
    • Is oestrogen receptor- {beta} a predictor of endocrine therapy responsiveness in human breast cancer? [2006]
    • Clinical trials with retinoids for breast cancer chemoprevention [2006]
    • The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers [2005]
    • The NF{kappa}B pathway and endocrine-resistant breast cancer [2005]
    • Overview of the impact of conventional systemic therapies on breast cancer [2005]
    • Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer [2005]
    • Growth factor signalling in clinical breast cancer and its impact on response to conventional therapies: the Edinburgh experience [2005]
    • Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity [2005]
    • Effects of estrogen deprivation due to breast cancer treatment [2004]
  • Japanese Journal of Clinical Oncology
    • Current Trends and Controversies over Pre-operative Chemotherapy for Women with Operable Breast Cancer [2007]
    • Validation and Problems of St-Gallen Recommendations of Adjuvant Therapy for Node-negative Invasive Breast Cancer in Japanese Patients [2001]
  • Journal of Clinical Endocrinology & Metabolism
    • To Block Estrogen’s Synthesis or Action: That Is the Question [2002]
  • Journal of Experimental & Clinical Cancer Research
    • Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007 [2009]
  • Journal of Nutrition
    • Nutritional Approaches to Late Toxicities of Adjuvant Chemotherapy in Breast Cancer Survivors [2003]
  • Journal of the National Cancer Institute
    • Risk of Cardiac Death After Adjuvant Radiotherapy for Breast Cancer [2005]
    • Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis [2005]
    • Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes [2001]
    • International consensus panel on the treatment of primary breast cancer [1998]
  • Medical Journal of Australia
    • Systemic adjuvant therapies for early breast cancer: 15-year results for recurrence and survival [2005]
    • Breast cancer in Western Australia: clinical practice and clinical guidelines [2004]
    • Implementing clinical practice guidelines: a community-based audit of breast cancer treatment [2000]
  • Yonsei Medical Journal
    • Psychiatric Care for Patients with Breast Cancer [1999]
• {Related topics}
  • Clinical tools, medical calculators, unit conversions, statistics, clinical research tools
    • Treatment of breast cancer : Clinical tools, medical calculators
  • Guidelines
    • Breast cancer treatment: vinca alkaloids
    • Breast cancer treatment: tyrosine kinase inhibitors
    • Breast cancer treatment: taxanes
    • Breast cancer treatment: surgery, radiotherapy
    • Breast cancer treatment: monoclonal antibodies
    • Breast cancer treatment: bisphosphonates
    • Breast cancer treatment: aromatase inhibitors
    • Breast cancer treatment: antimetabolites
    • Breast cancer treatment: antiestrogens
    • Breast cancer treatment: anthracyclines
    • Breast cancer

Breast cancer treatment: anthracyclines

• Canada
  • Cancer Care Ontario
    • Epirubicin, as a Single Agent or in Combination, for Metastatic Breast Cancer [2003]
• United States of America
  • National Guideline Clearinghouse
    • The role of HER2/neu in systemic and radiation therapy for women with breast cancer: a clinical practice guideline. Program in Evidence-based Care [2006]
• Articles in journals
  • Annals of Oncology
    • Role of liposomal anthracyclines in breast cancer [2007]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: antiestrogens

• Canada
  • Canadian Task Force on Preventive Health Care
    • Chemoprevention of breast cancer: A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer [2001]
  • Cancer Care Ontario
    • Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: guideline recommendations [2008]
• International
  • Cochrane Library
    • Tamoxifen for early breast cancer [2009]
• United States of America
  • National Guideline Clearinghouse
    • Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: guideline recommendations. Program in Evidence-based Care [2008]
• Articles in journals
  • Annals of Surgical Oncology
    • Tamoxifen for the prevention of breast cancer in the high-risk woman [2000]
  • Cancer Research
    • Nuclear p21-Activated Kinase 1 in Breast Cancer Packs Off Tamoxifen Sensitivity [2006]
  • Endocrine-Related Cancer
    • Deciphering antihormone-induced compensatory mechanisms in breast cancer and their therapeutic implications [2007]
    • Pure oestrogen antagonists for the treatment of advanced breast cancer [2006]
    • Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA [2006]
    • Growth factor signalling and response to endocrine therapy: the Royal Marsden Experience [2005]
    • Growth factor signalling and resistance to selective oestrogen receptor modulators and pure anti-oestrogens: the use of anti-growth factor therapies to treat or delay endocrine resistance in breast cancer [2005]
    • Mechanisms of tamoxifen resistance [2004]
  • Journal of the National Cancer Institute
    • Is tamoxifen the Rosetta stone for breast cancer? [2003]
    • Is low-dose tamoxifen useful for the treatment and prevention of breast cancer? [2003]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: antimetabolites

• Canada
  • Cancer Care Ontario
    • The role of Gemcitabine in the management of metastatic breast cancer : a clinical practice guideline [2007]
    • Capecitabine in stage IV breast cancer [2003]
• United Kingdom
  • Health Technology Assessment
    • The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation [2007]
    • Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda) for locally advanced and/or metastatic breast cancer [2004]
  • National Institute for Health and Clinical Excellence
    • Breast cancer - gemcitabine [2007]
  • NHS Quality Improvement Scotland
    • NICE (Single) Technology Appraisal Guidance No 116 Gemcitabine for the treatment of metastatic breast cancer [2007]
• United States of America
  • National Guideline Clearinghouse
    • Gemcitabine for the treatment of metastatic breast cancer. National Institute for Health and Clinical Excellence [2007]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: aromatase inhibitors

• Australia
  • National Breast and Ovarian Cancer Centre
    • Aromatase inhibitors adjuvant endocrine therapy post-menopausal receptor-positive early bc - NBOCC [2006]
• Canada
  • Cancer Care Ontario
    • The role of aromatase inhibitors in adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer : a clinical practice guideline [2007]
    • The role of Aromatase inhibitors in the treatment of postmenopausal women with metastatic breast cancer [2003]
• International
  • Cochrane Library
    • Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women [2009]
• Sweden
  • Swedish Council on Technology Assessment in Health Care
    • Aromatase Inhibitors in Breast Cancer [2005]
• United Kingdom
  • Attract
    • What evidence is there that arimidex (anastrozole) is better than tamoxifen for oestrogen receptor positive breast cancer? [2005]
  • Bandolier
    • Aromatase inhibitors in advanced breast cancer [2006]
  • Health Technology Assessment
    • Hormonal therapies for early breast cancer [2007]
  • National Institute for Health and Clinical Excellence
    • Breast cancer (early) - hormonal treatments [2006]
  • NHS Quality Improvement Scotland
    • NICE Technology Appraisal Guidance No 112 Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer [2006]
• United States of America
  • American Society of Clinical Oncology
    • American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Status Report 2004 [2005]
    • Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Status Report 2004 [2004]
  • National Guideline Clearinghouse
    • The role of aromatase inhibitors in adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: a clinical practice. Program in Evidence-based Care [2008]
    • American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor–positive breast cancer: status report 2004 [2004]
• Articles in journals
  • Annals of Oncology
    • Latest developments in local treatment: radiotherapy for early breast cancer [2005]
  • Breast Cancer Research
    • Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions [2005]
  • CA - A Cancer Journal for Clinicians
    • Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Patients With Early Stage Breast Cancer [2005]
  • Clinical Cancer Research
    • Aromatase Inhibition: Translation into a Successful Therapeutic Approach [2005]
  • Endocrine Journal
    • Aromatase in human breast carcinoma as a key regulator of intratumoral sex steroid concentrations [2008]
  • Endocrine Reviews
    • Aromatase Inhibitors in the Treatment of Breast Cancer [2005]
  • Endocrine-Related Cancer
    • Menopausal symptoms and adjuvant therapy-associated adverse events [2008]
    • Aromatase inhibitors for breast cancer: different structures, same effects? [2008]
    • Novel concepts for the chemoprevention of breast cancer through aromatase inhibition [2006]
  • Journal of Postgraduate Medicine
    • Exemestane: A milestone against breast cancer [2007]
  • Medical Journal of Australia
    • The aromatase inhibitors in early breast cancer: who, when, and why? [2005]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: bisphosphonates

• Canada
  • Cancer Care Ontario
    • Use of Bisphosphonates in women with breast cancer [2004]
• International
  • Cochrane Library
    • Bisphosphonates for breast cancer [2009]
• United States of America
  • American Society of Clinical Oncology
    • 2003 Update on the Role of Bisphosphonates and Bone Health Issues in Women With Breast Cancer [2003]
    • Role of Bisphosphonates in Breast Cancer [2000]
  • National Guideline Clearinghouse
    • Use of bisphosphonates in women with breast cancer. Practice Guidelines Initiative [2004]
• Articles in journals
  • Annals of Oncology
    • Bisphosphonates in breast cancer [2005]
  • Breast Cancer Research
    • The role of bisphosphonates in breast cancer: The present and future role of bisphosphonates in the management of patients with breast cancer [2002]
    • The role of bisphosphonates in breast cancer: Direct effects of bisphosphonates on breast cancer cells [2002]
    • The role of bisphosphonates in breast cancer: Development of bisphosphonates [2002]
    • The role of bisphosphonates in breast cancer: Actions of bisphosphonates in animal models of breast cancer [2002]
  • British Medical Journal
    • Recent developments in bisphosphonates for patients with metastatic breast cancer [2005]
  • Clinical Cancer Research
    • Oral Bisphosphonates as Adjuvant Therapy for Operable Breast Cancer [2006]
  • Endocrine-Related Cancer
    • Emerging anti-cancer molecular mechanisms of aminobisphosphonates [2006]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: monoclonal antibodies

• Australia
  • National Breast and Ovarian Cancer Centre
    • Trastuzumab for HER2-positive breast cancer: a systematic review [2007]
    • Summary for General Practitioners about the breast cancer drug Trastuzumab (Herceptin®) [2007]
    • Recommendations for Trastuzumab (Herceptin®) for treatment of HER2-positive breast cancer [2007]
• Canada
  • Cancer Care Ontario
    • The use of Bevacizumab in Metastatic Breast Cancer [2009]
    • The role of trastuzumab in adjuvant and neoadjuvant therapy in women with HER2/neu-overexpressing breast cancer : a clinical practice guideline [2007]
• Sweden
  • Swedish Council on Technology Assessment in Health Care
    • Trastuzumab (herceptin) for metastasized breast cancer [2001]
• United Kingdom
  • Centre for Reviews and Dissemination, University of York
    • Deconstructing media coverage of trastuzumab (Herceptin): an analysis of national newspaper coverage [2008]
  • Health Technology Assessment
    • The clinical effectiveness of trastuzumab for breast cancer: a systematic review [2002]
  • Journal of Clinical Pathology
    • HER2 testing in the UK: consensus from a national consultation [2007]
  • National Institute for Health and Clinical Excellence
    • Breast cancer (advanced & metastatic) - bevacizumab (terminated appraisal) [2008]
    • Breast cancer (early) - trastuzumab [2006]
    • Breast cancer - trastuzumab [2002]
• United States of America
  • National Guideline Clearinghouse
    • The role of trastuzumab in adjuvant and neoadjuvant therapy in women with HER2/neu-overexpressing breast cancer: a clinical practice guideline. Program in Evidence-based Care [2006]
    • The role of trastuzumab (Herceptin®) in the treatment of women with HER2/neu-overexpressing metastatic breast cancer. Program in Evidence-based Care [2003]
• Articles in journals
  • Annals of Oncology
    • Adjuvant trastuzumab in early breast cancer [2006]
  • Breast Cancer
    • Vascular endothelial growth factor and bevacitumab in breast cancer [2007]
    • Perspective of trastuzumab treatment [2007]
    • Next generation molecular targeted agents for breast cancer: focus on EGFR and VEGFR pathways [2007]
  • Breast Cancer Research
    • Update on HER-2 as a target for cancer therapy: The ERBB2 promoter and its exploitation for cancer treatment [2001]
    • Update on HER-2 as a target for cancer therapy: Herceptin in the clinical setting [2001]
    • Update on HER-2 as a target for cancer therapy: HER2/neu peptides as tumour vaccines for T cell recognition [2001]
    • Update on HER-2 as a target for cancer therapy: Alternative strategies for targeting the epidermal growth factor system in cancer [2001]
  • Canadian Medical Association Journal
    • Testing for HER2-positive breast cancer: a systematic review and cost-effectiveness analysis [2007]
  • Circulation
    • Trastuzumab in the treatment of metastatic breast cancer : anticancer therapy versus cardiotoxicity [2000]
  • Journal of Cancer Research and Therapeutics
    • Trastuzumab: Is the new evidence revolutionary? [2006]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: surgery, radiotherapy

• Australia, New Zealand
  • Royal Australasian College of Surgeons
    • Intraoperative Radiotherapy in Early Stage Breast Cancer [2002]
• Canada
  • Cancer Care Ontario
    • Surgical Management of Early Stage Invasive Breast Cancer [2003]
  • Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer
    • Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy [2004]
    • Clinical practice guidelines for the care and treatment of breast cancer: 6. Breast radiotherapy after breast-conserving surgery (2003 update) [2003]
    • Clinical practice guidelines for the care and treatment of breast cancer: Mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer (summary of the 2002 update) [2002]
    • Clinical practice guidelines for the care and treatment of breast cancer: 3. Mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer (2002 update) [2002]
    • Clinical practice guidelines for the care and treatment of breast cancer: 4. Axillary dissection [1998]
• Europe
  • European Society of Mastology
    • The curative role of radiotherapy in the treatment of operable breast cancer [2002]
    • Quality control in prophylactic mastectomy for women at high risk of breast cancer [2002]
    • Quality control in the locoregional treatment of breast cancer [2001]
• International
  • Cochrane Library
    • Radiotherapy for early breast cancer [2009]
    • Prophylactic mastectomy for the prevention of breast cancer [2009]
    • Post-operative radiotherapy for ductal carcinoma in situ of the breast [2009]
    • Ovarian ablation for early breast cancer [2009]
    • Fraction size in radiation treatment for breast conservation in early breast cancer [2009]
• United Kingdom
  • British Association of Surgical Oncology
    • Surgical guidelines for the management of breast cancer [2009]
    • Oncoplastic Breast Surgery - a guide to good practice [2007]
    • Guidelines for the management of symptomatic breast disease [2005]
  • National Institute for Health and Clinical Excellence
    • Endoscopic mastectomy and endoscopic wide local excision for breast cancer [2009]
    • Brachytherapy as the sole method of adjuvant radiotherapy for breast cancer after local excision [2008]
• United States of America
  • American College of Radiology
    • Postmastectomy Radiotherapy [2008]
    • Practice Guideline for the Management of Ductal Carcinoma In-Situ of the Breast (DCIS) [2006]
    • Practice Guideline for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma [2006]
    • Local Regional Recurrence and Salvage Surgery - Breast Cancer [2006]
    • Ductal Carcinoma in Situ [2006]
  • American Society of Breast Surgeons
    • Official Statements [Collection of guidelines]
  • American Society of Clinical Oncology
    • Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology [2001]
  • Institute for Clinical Systems Improvement
    • Bilateral Prophylactic Mastectomy for the Prevention of Breast Cancer [1999]
  • National Guideline Clearinghouse
    • ACR Appropriateness Criteria® postmastectomy radiotherapy [2008]
    • ACR Appropriateness Criteria® conservative surgery and radiation-stage I and II breast carcinoma [2008]
    • Radiotherapy for breast cancer in countries with limited resources: program implementation and evidence-based recommendations. Breast Health Global Initiative [2006]
    • Local regional recurrence (LR) and salvage surgery--breast cancer. American College of Radiology [2006]
    • Ductal carcinoma in situ. American College of Radiology [2006]
• Articles in journals
  • Acta Oncologica
    • Timing of breast cancer surgery in relation to the menstrual cycle - The rise and fall of a hypothesis [2008]
  • American Family Physician
    • Breast-Conserving Surgery for Breast Cancer [2002]
  • Annals of Surgical Oncology
    • Minimally Invasive Ablation Techniques in Breast Cancer Treatment [2002]
    • Long-Term Complications of Breast-Conservation Therapy: Can the Incidence Be Reduced? [2002]
    • Integrating Surgery and Radiotherapy to Reduce Toxicity While Maintaining Local Control for Breast Cancer: A Fine Balance [2002]
    • Can Specific Axillary Radiotherapy Be Omitted in Undissected, Clinically Node-Negative Patients Who Undergo Breast-Conserving Therapy? [2002]
    • The impact of prophylactic axillary node dissection on breast cancer survival - a Bayesian meta-analysis [1999]
  • Breast Cancer
    • Quality of life of breast cancer patients and types of surgery for breast cancer--current status and unresolved issues [2007]
  • CA - A Cancer Journal for Clinicians
    • Standard for the Management of Ductal Carcinoma In Situ of the Breast (DCIS) [2002]
    • Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma [2002]
  • Canadian Family Physician
    • Radiation treatment for breast cancer [2002]
  • Canadian Journal of Surgery
    • Surgical management of early stage invasive breast cancer: a practice guideline [2005]
  • Cancer Control: Journal of the Moffitt Cancer Center
    • Cardiac mortality and morbidity after breast cancer treatment [2008]
  • Japanese Journal of Clinical Oncology
    • Evidence-Based Risk Factors for Seroma Formation in Breast Surgery [2006]
  • Journal of Cancer Research and Therapeutics
    • External hypofractionated whole-breast radiotherapy: Now where does accelerated partial breast irradiation stand? [2007]
    • Breast cancer radiotherapy and cardiac risk: The 15-year paradox! [2007]
  • Journal of the National Cancer Institute
    • Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality [2004]
    • Ovarian ablation as adjuvant therapy for premenopausal women with breast cancer--another step forward [2003]
    • Inflammatory breast issue [2003]
  • Pathology Oncology Research
    • The role of boost irradiation in the conservative treatment of stage I-II breast cancer [2001]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: taxanes

• Australia
  • National Breast and Ovarian Cancer Centre
    • Recommedations for use of Taxane chemotherapy regimens for treatment of early breast cancer [2008]
    • TAXRW - Neoadjuvant treatment of early breast cancer - a systematic review [2007]
• Canada
  • Cancer Care Ontario
    • Adjuvant taxane therapy for women with early-stage, invasive breast cancer: a clinical practice guideline [2007]
    • The role of taxanes in neoadjuvant chemotherapy for women with non-metastatic breast cancer [2004]
    • The Role of the Taxanes in the Management of Metastatic Breast Cancer [2003]
• International
  • Cochrane Library
    • Taxane containing regimens for metastatic breast cancer (Cochrane Review [2009]
• United Kingdom
  • Health Technology Assessment
    • Taxanes for the adjuvant treatment of early breast cancer [2007]
  • National Institute for Health and Clinical Excellence
    • Breast cancer (early) - paclitaxel [2006]
    • Breast cancer (early) - docetaxel [2006]
    • Breast cancer - taxanes - review [2001]
  • NHS Quality Improvement Scotland
    • NICE Single Technology Appraisal No108: Paclitaxel for the adjuvant treatment of early node-positive [2006]
    • NICE Single Technology Appraisal No 109: Docetaxel for the adjuvant treatment of early node-positive breast cancer [2006]
• United States of America
  • National Guideline Clearinghouse
    • Adjuvant taxane therapy for women with early-stage, invasive breast cancer. Program in Evidence-based Care [2006]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: tyrosine kinase inhibitors

• United Kingdom
  • National Institute for Health and Clinical Excellence
    • Breast cancer (advanced or metastatic) - lapatinib [2008]
• Articles in journals
  • Annals of Oncology
    • Lapatinib in breast cancer [2007]
  • Breast Cancer
    • Does lapatinib, a small-molecule tyrosine kinase inhibitor, constitute a breakthrough in the treatment of breast cancer? [2007]
  • Endocrine-Related Cancer
    • Overview of tyrosine kinase inhibitors in clinical breast cancer [2005]
    • Clinical trials of intracellular signal transductions inhibitors for breast cancer -- a strategy to overcome endocrine resistance [2005]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: vinca alkaloids

• Canada
  • Cancer Care Ontario
    • Vinorelbine in Stage IV Breast Cancer [2003]
• United Kingdom
  • Health Technology Assessment
    • The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation [2002]
  • National Institute for Health and Clinical Excellence
    • Breast Cancer - Vinorelbine [2002]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast imaging

• Australia
  • National Breast and Ovarian Cancer Centre
    • Synoptic breast imaging report [2007]
• Australia, New Zealand
  • Australasian Society for Ultrasound in Medicine
    • Breast Examination and Reporting [1999]
• Canada
  • Cancer Care Ontario
    • Diagnostic imaging in breast cancer [2006]
• United Kingdom
  • Health Technology Assessment
    • Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers [2007]
  • Royal College of Radiologists
    • Guidance on Screening and Symptomatic Breast Imaging [2003]
• United States of America
  • American College of Radiology
    • ACR Practice Guideline for the Performance of a Breast Ultrasound Examination [2007]
    • Stage I Breast Carcinoma [2006]
    • Palpable Breast Masses [2006]
    • ACR Practice Guideline for the Performance of Magnetic Resonance Imaging (MRI) of the Breast [2006]
    • Nonpalpable Breast Masses [2005]
    • Breast Microcalcifications [2005]
  • Institute for Clinical Systems Improvement
    • Magnetic Resonance Imaging (MRI) for the Detection of Breast Abnormalities [2003]
  • National Guideline Clearinghouse
    • (1) ACS guidelines for breast cancer screening: update 2003. (2) American Cancer Society Guideline for breast screening with MRI as an adjunct to mammography (2007). American Cancer Society [2007]
    • Diagnostic imaging in breast cancer. Program in Evidence-based Care [2006]
    • Work-up of nonpalpable breast masses. American College of Radiology [2005]
    • Appropriate imaging work-up of breast microcalcifications. American College of Radiology [2005]
    • Procedure guideline for breast scintigraphy. Society of Nuclear Medicine [2004]
• Articles in journals
  • Australian Family Physician
    • The role of breast MRI in clinical practice [2009]
  • Breast Cancer Research
    • Molecular imaging as a tool for translating breast cancer science [2008]
    • Breast imaging technology: Imaging biochemistry - applications to breast cancer [2001]
    • Breast imaging technology: Application of magnetic resonance imaging to early detection of breast cancer [2001]
  • British Journal of Radiology
    • MRI of the breast [2000]
    • Localization of breast lesions shown only on MRI--a review for the UK Study of MRI Screening for Breast Cancer. Advisory Group of MARIBS [2000]
  • Israel Medical Association Journal
    • Current Dilemmas and Future Perspectives for Breast Cancer Screening with a Focus upon Optimization of Magnetic Resonance Spectroscopic Imaging by Advances in Signal Processing [2004]
  • Journal of the American Board of Family Practice
    • Current Role of Magnetic Resonance Imaging in Breast Imaging: A Primer for the Primary Care Physician [2005]
  • RadioGraphics
    • Recognizing and Interpreting Artifacts and Pitfalls in MR Imaging of the Breast [2007]
    • MR Ductography: Comparison with Conventional Ductography as a Diagnostic Method in Patients with Nipple Discharge [2007]
    • Complex Cystic Breast Masses: Diagnostic Approach and Imaging-Pathologic Correlation [2007]
    • Common and Unusual Diseases of the Nipple-Areolar Complex [2007]
    • Breast Lesions Incidentally Detected with CT: What the General Radiologist Needs to Know [2007]
    • Patterns of Enhancement on Breast MR Images: Interpretation and Imaging Pitfalls [2006]
    • How to Optimize Clinical Breast MR Imaging Practices and Techniques on Your 1.5-T System [2006]
    • Radiologic Evaluation of Uncommon Inflammatory and Reactive Breast Disorders [2005]
    • Detection of Locoregional and Distant Recurrences in Breast Cancer Patients by Using FDG PET [2002]
    • Ductography: How To and What If? [2001]
  • Radiology
    • The Current Status of Breast MR Imaging. Part I. Choice of Technique, Image Interpretation, Diagnostic Accuracy, and Transfer to Clinical Practice [2007]
    • MR Imaging of the Breast for the Detection, Diagnosis, and Staging of Breast Cancer [2001]
  • Singapore Medical Journal
    • Imaging of giant breast masses with pathological correlation [2004]
• {Related topics}
  • Guidelines
    • Mammography
    • Breast cancer screening
    • Breast cancer
    • Benign breast diseases

Breast plastic surgery

• Australia, New Zealand
  • Royal Australasian College of Surgeons
    • Autologous Fat Transfer for Breast Augmentation [2002]
• Netherlands
  • Health Council of the Netherlands
    • Health risks of silicone breast implants [1999]
• United Kingdom
  • National Institute for Health and Clinical Excellence
    • Laparoscopic mobilisation of the greater omentum for breast reconstruction [2008]
• United States of America
  • Food and Drug Administration
    • Breast Implants [Collection of guidelines]
  • Madigan Army Medical Center
    • Macromastia (Symptomatic) Referral Guidelines [2004]
    • Breast Reconstruction Referral Guidelines [2004]
• Articles in journals
  • American Journal of Psychiatry
    • Cosmetic Breast Augmentation and Suicide [2007]
  • Australian Family Physician
    • Cosmetic and reconstructive breast surgery [2006]
  • British Medical Journal
    • Breast reconstruction [2005]
• {Related topics}
  • Guidelines
    • Breast cancer treatment
    • Breast cancer
    • Benign breast diseases

Familial breast cancer

• Australia
  • Genetics in Family Medicine: the Australian Handbook for General Practitioners
    • Breast cancer [2007]
• Canada
  • Chronic Diseases in Canada
    • Do work-related breast cancer risks in pre-menopausal women depend on family history? [2004]
• International
  • Cochrane Library
    • Cancer genetic risk assessment for individuals at risk of familial breast cancer [2009]
• Sweden
  • Swedish Council on Technology Assessment in Health Care
    • Presymptomatic diagnosis of hereditary breast cancer [2000]
• United Kingdom
  • Health Technology Assessment
    • Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions [2005]
  • National Institute for Health and Clinical Excellence
    • Familial breast cancer [2006]
• United States of America
  • CDC National Office of Public Health Genomics
    • Breast Cancer [2003]
  • National Guideline Clearinghouse
    • The use of magnetic resonance imaging of the breast (MRIB) for screening of women at high risk of breast cancer. American Society of Breast Disease [2004]
• Articles in journals
  • Annals of Oncology
    • Genetic counselling in breast and colorectal cancer [2005]
  • Australian Family Physician
    • Family history of breast cancer [2006]
    • An approach to the patient with a family history of breast cancer. Benefits, harms and making an informed choice [2006]
  • Breast Cancer Research
    • Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories? [2008]
    • More breast cancer genes? [2001]
  • British Medical Journal
    • Family history of breast cancer [2005]
    • Advice about mammography for a young woman with a family history of breast cancer [2001]
  • Canadian Medical Association Journal
    • Second-guessing a second primary [1999]
  • Cancer Epidemiology Biomarkers & Prevention
    • Uptake Rates for Breast Cancer Genetic Testing: A Systematic Review [2006]
    • Intention to Pursue Genetic Testing for Breast Cancer among Women due for Screening Mammography [2003]
  • Cancer Informatics
    • Use of Gene Expression Profiles of Peripheral Blood Lymphocytes to Distinguish BRCA1 Mutation Carriers in High Risk Breast Cancer Families [2009]
  • Cancer Research
    • Estrogens, BRCA1, and Breast Cancer [2000]
  • Endocrine-Related Cancer
    • BRCA1 in hormonal carcinogenesis: basic and clinical research [2005]
  • Family Medicine
    • Genetic susceptibility to breast cancer: teaching points [2003]
  • Journal of the American Board of Family Practice
    • Patients with a Family History of Cancer: Identification and Management [2005]
  • Journal of the National Cancer Institute
    • Risk-reduction mastectomy: clinical issues and research needs [2001]
  • Medical Journal of Australia
    • Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review [2003]
  • Nucleic Acids Research
    • BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution [2006]
• {Related topics}
  • Guidelines
    • Hereditary gynecologic cancer, genetic predisposition
    • Gynecologic oncology
    • Breast cancer risk, biological markers
    • Breast cancer

Gynecomastia

• Articles in journals
  • British Medical Journal
    • Endocrine treatment of physiological gynaecomastia [2003]
  • Cleveland Clinic Journal of Medicine
    • Gynecomastia: Its features, and when and how to treat it [2004]
  • RadioGraphics
    • Mammographic Appearances of Male Breast Disease [1999]
• {Related topics}
  • Guidelines
    • Male hypogonadism, andropause
    • Benign breast diseases

Mammography

• Australia
  • National Breast and Ovarian Cancer Centre
    • Over-diagnosis from mammography screening - NBOCC Position statement [2008]
• Canada
  • Canadian Task Force on Preventive Health Care
    • Screening Mammography among Women Aged 40-49 Years at Average Risk of Breast Cancer [2001]
    • Preventive health care, 2001 update: screening mammography among women aged 40–49 years at average risk of breast cancer [2001]
  • Guidelines and Protocols Advisory Committee - British Columbia
    • Mammography - Protocol for the Use of Diagnostic Facilities [2007]
  • Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer
    • Clinical practice guidelines for the care and treatment of breast cancer: 2. Investigation of lesions detected by mammography [1998]
• International
  • Cochrane Library
    • Screening for breast cancer with mammography [2009]
    • Interventions for relieving the pain and discomfort of screening mammography [2009]
• Netherlands
  • Health Council of the Netherlands
    • The Benefit of Population Screening for Breast Cancer With Mammography [2002]
• United Kingdom
  • Health Technology Assessment
    • Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography [2005]
  • NHS Quality Improvement Scotland
    • Determining the most clinically and cost-effective way of implementing digital mammography services for breast screening in NHSScotland [2008]
    • Comparison of digital mammography and film screen mammography [2004]
• United States of America
  • Agency for Healthcare Research and Quality
    • The Cost-Effectiveness of Screening Mammography Beyond Age 65: A Systematic Review [2003]
  • American College of Physicians
    • Screening Mammography in Women 40 to 49 Years of Age: A Systematic Review for the American College of Physicians [2007]
  • American College of Radiology
    • Practice Guideline for Determinants of Image Quality in Digital Mammograph [2007]
    • ACR Practice Guideline for the Performance of Whole Breast Digital Mammography [2006]
    • ACR Practice Guideline for the Performance of Screening Mammography [2006]
    • ACR Practice Guideline for the Performance of Diagnostic Mammography [2006]
  • Centers for Medicare and Medicaid Services
    • Mammography [2007]
  • Food and Drug Administration
    • Mammography Quality Standards Act and Program [Collection of guidelines]
  • Institute for Clinical Systems Improvement
    • Computer Aided Detection of Breast Cancer [2004]
    • North Clinic Improvement Case Report: Application of Advanced Access Changes to Improve Mammography Waiting Time and Rates [2001]
  • Madigan Army Medical Center
    • Mammography Referral Guideline [2006]
  • National Guideline Clearinghouse
    • Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American College of Physicians [2007]
• Articles in journals
  • American Family Physician
    • Should We Offer Routine Breast Cancer Screening with Mammography? [2003]
  • Annals of Internal Medicine
    • Systematic review: the long-term effects of false-positive mammograms [2007]
  • BMC Medical Informatics and Decision Making
    • What is the point: will screening mammography save my life? [2009]
  • Breast Cancer Research
    • Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence [2008]
    • Mammographic density. Measurement of mammographic density [2008]
  • British Medical Journal
    • Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends [2009]
    • Women need better information about routine mammography [2003]
    • Two view mammography at incident screens: cost effectiveness analysis of policy options [1999]
  • Canadian Medical Association Journal
    • Screening mammography for women aged 40–49: Are we off the fence yet? [2001]
  • Cancer Epidemiology Biomarkers & Prevention
    • Interventions Targeted toward Patients to Increase Mammography Use [1999]
    • Effectiveness of Interventions Designed to Increase Mammography Use: A Meta-Analysis of Provider-targeted Strategies [1999]
  • Journal of the American Board of Family Practice
    • BI-RADS Classification for Management of Abnormal Mammograms [2006]
    • Competing demands in the office visit: what influences mammography recommendations? [2001]
  • RadioGraphics
    • Columnar Cell Lesions of the Breast: Mammographic Findings with Histopathologic Correlation [2007]
    • Focal Asymmetric Densities Seen at Mammography: US and Pathologic Correlation [2002]
    • Image Processing Algorithms for Digital Mammography: A Pictorial Essay [2000]
  • Radiology
    • Age-related Accuracy of Screening Mammography: How Should It Be Measured? [2000]
• {Related topics}
  • Clinical tools, medical calculators, unit conversions, statistics, clinical research tools
    • Mammography : Clinical tools, medical calculators
  • Guidelines
    • Breast imaging
    • Breast cancer screening
    • Breast cancer
    • Benign breast diseases

Mastitis

• International
  • Cochrane Library
    • Antibiotics for mastitis in breastfeeding women [2009]
• United States of America
  • Academy of BreastFeeding Medicine
    • Mastitis [2008]
  • National Guideline Clearinghouse
    • Mastitis. Academy of Breastfeeding Medicine [2008]
• WHO
  • World Health Organization
    • Mastitis. Causes and Management [2000]
• Articles in journals
  • American Family Physician
    • Management of Mastitis in Breastfeeding Women [2008]
  • Applied and Environmental Microbiology
    • Oral Administration of Lactobacillus Strains Isolated from Breast Milk as an Alternative for the Treatment of Infectious Mastitis during Lactation [2008]
  • Archives of Disease in Childhood
    • The challenge of mastitis [2003]
  • BMC Infectious Diseases
    • PCR-DGGE assessment of the bacterial diversity of breast milk in women with lactational infectious mastitis [2008]
• {Related topics}
  • Guidelines
    • Breastfeeding complications
    • Benign breast diseases

Sentinel lymph node biopsy

• Australia
  • Medical Services Advisory Committee
    • Sentinel lymph node biopsy in breast cancer [2005]
  • National Breast and Ovarian Cancer Centre
    • The use of sentinel node biopsy in early (operable) breast cancer [2009]
    • Recommendations for use of Sentinel node biopsy in early (operable) breast cancer [2008]
    • Sentinel Node Biopsy for Early Breast Cancer: a systematic review [2007]
• Canada
  • Cancer Care Ontario
    • Sentinel Lymph Node Biopsy in Early-stage Breast Cancer: Guideline Recommendations [2009]
  • Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer
    • Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy [2001]
• United Kingdom
  • National Institute for Health and Clinical Excellence
    • Endoscopic axillary lymph node retrieval for breast cancer [2005]
• United States of America
  • American Society of Clinical Oncology
    • Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer [2005]
    • American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer [2005]
  • Institute for Clinical Systems Improvement
    • Lymphatic Mapping with Sentinel Lymph Node Biopsy for Breast Cancer [2002]
  • National Guideline Clearinghouse
    • American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer [2005]
• Articles in journals
  • Annals of Oncology
    • Development of axillary surgery in breast cancer [2005]
  • Annals of Surgical Oncology
    • Utilization of Sentinel Lymph Node Mapping to Determine Pathologic Outcomes for Patients Receiving Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer [2002]
    • The Results of the Department of Defense's Breast Lymphatic Mapping Study [2002]
    • Intraoperative Sentinel Node Assessment Is a Touchy Subject [2002]
    • Sentinel Node Biopsy for Patients With DCIS: A Dangerous and Unwarranted Direction [2001]
    • Modification of the Sentinel Node Technique: It Was a Hit in New York, But Will It Play in Poughkeepsie? [2001]
    • Expanding Indications for Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Breast Cancer Population [2001]
    • Guidelines for the safe use of radioactive materials during localization and resection of the sentinel lymph node [1999]
  • Breast Cancer
    • Sentinel node biopsy for breast cancer: technical aspects and controversies [2007]
  • Breast Cancer Research
    • Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer [2001]
    • Clinical aspects of sentinel node biopsy [2001]
  • Indian Journal of Cancer
    • Sentinel Lymph Node Biopsy in the Management of Breast Cancer [2003]
  • Journal of Medical Investigation
    • Current status of sentinel lymph node navigation surgery in breast and gastrointestinal tract [2007]
  • Journal of the National Cancer Institute
    • Is positron emission tomography an accurate non-invasive alternative to sentinel lymph node biopsy in breast cancer patients? [2003]
  • RadioGraphics
    • US-guided Core Needle Biopsy of Axillary Lymph Nodes in Patients with Breast Cancer: Why and How to Do It [2007]
• {Related topics}
  • Clinical tools, medical calculators, unit conversions, statistics, clinical research tools
    • Sentinel lymph node biopsy : Clinical tools, medical calculators
  • Guidelines
    • Breast cancer
    • Breast biopsy, breast pathology